Related Experiment Video
Updated: Jul 19, 2026

08:44
An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices
Published on: August 21, 2020
7.3K
Optimization of hemocompatibility metrics in ventricular assist device design using machine learning and CFD-based
Mohamed Bounouib1, Mourad Taha-Janan1, Wajih Maazouzi2
1Laboratory of Applied Mechanics and Technologies, ENSAM, Mohammed V University in Rabat, Rabat, Morocco.
The International Journal of Artificial Organs
|June 6, 2025
Summary
This study optimized ventricular assist device (VAD) rotors for better hemocompatibility using CFD and machine learning. The improved design significantly reduces blood damage, enhancing patient outcomes for heart failure.
Area of Science:
- Biomedical Engineering
- Cardiovascular Devices
- Computational Fluid Dynamics
Background:
- Ventricular assist devices (VADs) are critical for end-stage heart failure.
- Optimizing VAD design requires balancing hydraulic efficiency and hemocompatibility to minimize blood damage.
- Current VAD designs face challenges in preventing adverse blood-material interactions.
Purpose of the Study:
- To develop and validate a multi-objective optimization framework for improving VAD rotor hemocompatibility.
- To identify optimal design parameters for VAD rotors that minimize blood damage.
- To enhance the safety and efficacy of VADs for patients with heart failure.
Main Methods:
- Integrated computational fluid dynamics (CFD) with Random Forest Regression (RFR) and Bayesian optimization.
- Utilized a D-optimal design of experiments to optimize seven key VAD rotor parameters.
- Employed a Carreau-Yasuda blood model and mesh independence analysis in CFD simulations.
Main Results:
- The RFR surrogate model achieved high predictive accuracy (R² > 0.84) for hemocompatibility metrics.
- Optimized design reduced shear stress exposure, achieving 97.24% of blood flow below 50 Pa.
- Demonstrated significant reductions in hemolysis index (0.01%) and platelet activation (1x10⁻⁶%).
Conclusions:
- The proposed optimization framework systematically enhances VAD hemocompatibility.
- The optimized VAD rotor design offers substantial improvements in blood-damage reduction.
- Further experimental validation is recommended to confirm computational findings under physiological conditions.

